Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...
Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...
Researchers found that adherence to the first and second annual screenings was 61% and 51%, respectively, with higher lung ...
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Source: Getty Images While radiation therapy and chemo are separate treatments, they both work by damaging or killing cancer cells. Our easy-to-read fact sheets provide clinicians with reliable ...
Treatment includes chemotherapy, immunotherapy, targeted therapy, radiation and surgery in the early stages. Immunotherapy drugs such as Libtayo offer new options for advanced cases. Like NSCLC, BCC ...
Medicare covers prescribed chemotherapy drugs. How and where a person receives chemotherapy helps determine which Medicare part provides the coverage. When a person receives a cancer diagnosis ...
Also called an implanted port, port-a-cath or medi-port, a chemo port has two parts: the port and the catheter. The port is a quarter-sized plastic or metal disc. (If you have the metal kind ...
Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. Your doctor and nurse will talk to you about the chemotherapy that is best for your situation. They will explain how long your ...
and chemotherapy. The THIO-101 study in 3L will enroll up to 48 patients with two arms: Arm 1, continuing the evaluation of THIO sequenced with Libtayo ® (cemiplimab); and Arm 2, evaluating THIO ...
and chemotherapy. The THIO-101 study in 3L will enroll up to 48 patients with two arms: Arm 1, continuing the evaluation of THIO sequenced with Libtayo ® (cemiplimab); and Arm 2, evaluating THIO as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results